Plasminogen Deficiency, Type I: Clinical Trials

4 trials for Plasminogen Deficiency, Type I, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 available, 1 enrolling by invitation. 2 Phase 3, 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 32Completed 1, Enrolling by invitation 1
Phase 11Completed 1
Phase 21Completed 1

Follow Plasminogen Deficiency, Type I: new trials by email Literature Review of Plasminogen Deficiency, Type I trials Research Report on Plasminogen Deficiency, Type I

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Allogenic Plasma Aliquots in the Treatment of Ligneous Conjunctivitis
Allogenic plasma aliquots, a source of plasminogen - Ligneous Conjunctivitis, Left Eye
Phase 3Enrolling by invitationDorothy Bautista, MD12025-05-012024-11-22
A Phase 1 Study of ProMetic Plasminogen (Human) Intravenous in Adults and Children With Plasminogen Deficiency
Plasminogen (Human) Intravenous - Type I Plasminogen Deficiency, Hypoplasminogenemia
Phase 1CompletedPrometic Biotherapeutics, Inc.72014-12-012017-08-29
Efficacy/Safety of Human Plasminogen Eye Drop in Ligneous Conjunctivitis Patients
Human Plasminogen - Ligneous Conjunctivitis
Phase 2 / Phase 3CompletedKedrion S.p.A.122013-05-222023-01-25
Sponsor Initiated Expanded Access Protocol, Intermediate-Size Patient Population
Plasminogen - Ligneous Conjunctivitis
AvailableKedrion S.p.A.2023-10-05

Narrower conditions

Congenital Plasminogen Deficiency (2)

Interventions

Plasminogen (3)

Sponsors

Kedrion S.p.A. (2)  ·  Dorothy Bautista, MD (1)  ·  Prometic Biotherapeutics, Inc. (1)

Countries

United States (2)  ·  Canada (1)  ·  Italy (1)

Top investigators

Dorothy V Bautista, MD (1)

Results publications

PMID 35346720